Clinical Trials Browser

Phase NA × INDUSTRY × exemestane × Clear all

NCT01331421 2018-01-23

Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Phase NA Completed

Breast Neoplasms

NCT01331434 2018-01-23

Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

Phase NA Completed

Breast Neoplasms

NCT01331447 2018-01-23

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Phase NA Completed

Breast Neoplasms